Literature DB >> 33456605

Melatonin Levels Decrease in the Umbilical Cord in Case of Intrauterine Growth Restriction.

Andrii Mykolaiovych Berbets1, Adrian Mykhailovych Barbe1, Oksana Anatoliivna Andriiets1, Anatolii Volodymyrovych Andriiets1, Oleksandr Mykhailovych Yuzko1.   

Abstract

Intrauterine growth restriction (IUGR) is a common reason for perinatal morbidity and mortality. Also, it is often complicated with fetal distress. Melatonin is widely known as an anti-oxidant agent, and it might decrease the damage of tissues caused by hypoxia. It is also known that levels of pro- and anti-inflammatory cytokines are changed during pregnancy. Placental growth factor (PlGF) is responsible for the angiogenesis in the placenta. We aimed to investigate whether the level of melatonin, cytokines, and PlGF in umbilical blood after birth is different in the case of IUGR compared to normal fetuses. Fourteen women whose pregnancies were complicated with IUGR were included in the study group. The presence of IUGR was confirmed by ultrasound fetometry in the third pregnancy trimester, 30-36 weeks of gestation. All patients delivered their children vaginally after 37 weeks of pregnancy. The cases of severe fetal distress that required a caesarian section, obstetrical forceps, or vacuum extraction of the fetus were excluded from the study. We found that the concentrations of cytokines did not differ significantly between the groups. Also, no significant difference in the daytime of delivery was found between the groups. The concentrations of melatonin and PlGF in the umbilical blood at labor were significantly lowered in the case of IUGR compared to normal pregnancies. This fact, as we consider, is caused by altered production of melatonin and PlGF by the placenta. Therefore, the protective action of these two factors for the fetus at labor is decreased in IUGR. ©Carol Davila University Press.

Entities:  

Keywords:  ELISA – enzyme-linked immunosorbent assay; FLT-1 – fms-related tyrosine kinase-1; IL-1-β – interleukine-1-β; IL-10 – interleukine-10; IL-4 – interleukine-4; IL-6 – interleukine – 6; IUGR; IUGR – intrauterine growth restriction; PI – placental insufficiency; PlGF; PlGF – placental growth factor; Pregnancy; TNF-α – tumor necrotizing factor-α; VEGFR – vascular endothelial growth factor receptor; cytokines; melatonin; placenta; sFLT-1 – soluble fms-like tyrosine kinase-1

Year:  2020        PMID: 33456605      PMCID: PMC7803309          DOI: 10.25122/jml-2020-0128

Source DB:  PubMed          Journal:  J Med Life        ISSN: 1844-122X


  17 in total

1.  Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation.

Authors:  Ahmed Soliman; Andrée-Anne Lacasse; Dave Lanoix; Lucas Sagrillo-Fagundes; Véronique Boulard; Cathy Vaillancourt
Journal:  J Pineal Res       Date:  2015-04-20       Impact factor: 13.007

2.  Melatonin protects mice against stress-induced inflammation through enhancement of M2 macrophage polarization.

Authors:  Woo-Jin Yi; Tae Sung Kim
Journal:  Int Immunopharmacol       Date:  2017-05-12       Impact factor: 4.932

3.  Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.

Authors:  Samantha J Benton; Lesley M McCowan; Alexander E P Heazell; David Grynspan; Jennifer A Hutcheon; Christof Senger; Orlaith Burke; Yuen Chan; Jane E Harding; Julien Yockell-Lelièvre; Yuxiang Hu; Lucy C Chappell; Melanie J Griffin; Andrew H Shennan; Laura A Magee; Andrée Gruslin; Peter von Dadelszen
Journal:  Placenta       Date:  2016-03-23       Impact factor: 3.481

4.  Fetal Growth and Placental Growth Factor Umbilical Cord Blood Levels.

Authors:  Zoe A Broere-Brown; Sarah Schalekamp-Timmermans; Vincent W V Jaddoe; Eric A P Steegers
Journal:  Fetal Diagn Ther       Date:  2017-09-20       Impact factor: 2.587

5.  Effects of melatonin on cytokine release and healing of colonic anastomoses in an experimental sepsis model.

Authors:  Ömer Faik Ersoy; Namık Özkan; Zeki Özsoy; Hüseyin Ayhan Kayaoğlu; Erdinç Yenidoğan; Alper Çelik; Aziz Fikret Özuğurlu; Ebru Arabacı Çakır; Neşe Lortlar
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2016-07

6.  Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis.

Authors:  Mieko Shimada; Hiroyuki Seki; Michikazu Samejima; Mako Hayase; Fumie Shirai
Journal:  Biosci Trends       Date:  2016-02-06       Impact factor: 2.400

7.  Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.

Authors:  Juan C Mayo; Rosa M Sainz; Dun-Xian Tan; Rüdiger Hardeland; Josefa Leon; Carmen Rodriguez; Russel J Reiter
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

Review 8.  Potential Utility of Melatonin in Preeclampsia, Intrauterine Fetal Growth Retardation, and Perinatal Asphyxia.

Authors:  Lucia Marseglia; Gabriella D'Angelo; Sara Manti; Russel J Reiter; Eloisa Gitto
Journal:  Reprod Sci       Date:  2015-11-12       Impact factor: 3.060

Review 9.  Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes.

Authors:  Helen Sherrell; Liam Dunn; Vicki Clifton; Sailesh Kumar
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-30       Impact factor: 2.435

10.  Using Doppler ultrasound of the uterine and umbilical arteries and disordered angiogenesis markers (sFlt-1/PlGF) in unified monitoring of ischemic placental syndrome patients.

Authors:  Sebastian Kwiatkowski; Ewa Kwiatkowska; Rafał Rzepka; Barbara Dołegowska; Andrzej Torbe; Agata Bartosik-Sławińska
Journal:  Hypertens Pregnancy       Date:  2016-06-17       Impact factor: 2.108

View more
  2 in total

Review 1.  Effects of Antioxidant Intake on Fetal Development and Maternal/Neonatal Health during Pregnancy.

Authors:  Giorgia Sebastiani; Elisabet Navarro-Tapia; Laura Almeida-Toledano; Mariona Serra-Delgado; Anna Lucia Paltrinieri; Óscar García-Algar; Vicente Andreu-Fernández
Journal:  Antioxidants (Basel)       Date:  2022-03-28

Review 2.  Melatonin for Neonatal Encephalopathy: From Bench to Bedside.

Authors:  Raymand Pang; Adnan Advic-Belltheus; Christopher Meehan; Daniel J Fullen; Xavier Golay; Nicola J Robertson
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.